Vise Technologies’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.71M Hold
46,492
0.11% 149
2025
Q4
$5.71M Buy
46,492
+11,294
+32% +$1.37M 0.11% 149
2025
Q3
$3.91M Sell
35,198
-14,905
-30% -$1.69M 0.15% 142
2025
Q2
$5.55M Buy
+50,103
New +$5.33M 0.23% 96
2024
Q4
$2.48M Buy
26,838
+6,276
+31% +$565K 0.21% 103
2024
Q3
$1.72M Sell
20,562
-2,361
-10% -$180K 0.22% 97
2024
Q2
$1.57M Buy
22,923
+386
+2% +$25.8K 0.28% 80
2024
Q1
$1.65M Sell
22,537
-960
-4% -$73.8K 0.33% 71
2023
Q4
$1.9M Buy
23,497
+2,127
+10% +$166K 0.41% 61
2023
Q3
$1.6M Buy
21,370
+1,163
+6% +$89.5K 0.39% 65
2023
Q2
$1.56M Sell
20,207
-394
-2% -$31.4K 0.38% 63
2023
Q1
$1.71M Buy
20,601
+3,455
+20% +$286K 0.45% 49
2022
Q4
$1.47M Sell
17,146
-303
-2% -$24K 0.46% 48
2022
Q3
$1.08M Buy
17,449
+7,656
+78% +$483K 0.41% 50
2022
Q2
$605K Buy
9,793
+4,348
+80% +$269K 0.23% 106
2022
Q1
$324K Buy
+5,445
New +$348K 0.12% 159

Other funds holding GILD

Vise Technologies's GILD Position: Q1 2026 in Review

Vise Technologies held its Gilead Sciences (GILD) position steady in Q1 2026 at 46,492 shares worth $5.71M. The position accounts for 0.11% of the portfolio, ranked #149.

Vise Technologies first reported a position in GILD in Q1 2022 and has held it in 16 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Vise Technologies held 46,492 shares of Gilead Sciences worth $5.71M as of Q1 2026.
  • Vise Technologies left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.11% of Vise Technologies's portfolio in Q1 2026, its #149 holding.
  • Vise Technologies first reported a position in Gilead Sciences in Q1 2022 and has held it in 16 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.